You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Letters Anandamide as a Marker of Human Disease—Reply
Osama M. H. Habayeb; Anthony H. Taylor; Justin C. Konje
JAMA 2008; 300: 282.
[Extract][Full text][PDF]
Original Contributions Fetuin-A and Incident Diabetes Mellitus in Older Persons
Joachim H. Ix; Christina L. Wassel; Alka M. Kanaya; Eric Vittinghoff; Karen C. Johnson; Annemarie Koster; Jane A. Cauley; Tamara B. Harris; Steven R. Cummings; Michael G. Shlipak; for the Health ABC Study
JAMA 2008; 300: 182-188.
[Abstract][Full text][PDF]
Reviews Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
Alexander Thompson; Emanuele Di Angelantonio; Nadeem Sarwar; Sebhat Erqou; Danish Saleheen; Robin P. F. Dullaart; Bernard Keavney; Zheng Ye; John Danesh
JAMA 2008; 299: 2777-2788.
[Abstract][Full text][PDF][ eFigure and eTables ]
Editorials CETP Genes, Metabolic Effects, and Coronary Disease Risk
Original Contributions Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
Ruth Frikke-Schmidt; Børge G. Nordestgaard; Maria C. A. Stene; Amar A. Sethi; Alan T. Remaley; Peter Schnohr; Peer Grande; Anne Tybjærg-Hansen
JAMA 2008; 299: 2524-2532.
[Abstract][Full text][PDF]
Letters Glucose-Insulin-Potassium Therapy in Patients With STEMI
